SDH抑制通过NF-κB/STAT4通路平息类风湿关节炎发作相关的IL-1β+IFN-γ+巨噬细胞
本研究探讨抑制琥珀酸脱氢酶(SDH)对类风湿关节炎(RA)发作相关致病性巨噬细胞的作用。利用RA患者外周血来源巨噬细胞、滑膜组织及局部关节炎模型,发现TLR5刺激诱导IL-1β+NFKB1+IFN-γ+STAT4lo巨噬细胞呈现双相代谢重编程,SDH抑制可干预NF-κB/STAT4信号和氧化应激,恢复TCA酶表达和线粒体功能,并减轻局部滑膜炎。结论提示SDH是代谢-免疫检查点,靶向SDH可能同时缓解线粒体功能障碍和炎症。
要点
- TLR5、SDH与p65/NFKB1在RA滑膜CD14⁺巨噬细胞中共定位,疾病发作时循环中上调。
- SDH抑制可干预TLR5诱导的NF-κB/STAT4信号和氧化应激,恢复TCA酶表达和线粒体功能。
- 在TLR5驱动的局部滑膜炎中,SDH抑制减少F4/80⁺IL-1β+iNOS⁺SDH⁺巨噬细胞并减轻关节炎症。
核心结论
- SDH是RA致病性IL-1β+NFKB1+IFN-γ+STAT4lo巨噬细胞的代谢-免疫检查点。
- 靶向SDH可能同时解决疾病发作患者的线粒体功能障碍和炎症。
研究设计与样本
- 研究使用RA患者外周血来源巨噬细胞、滑膜组织以及局部关节炎模型。
- 方法包括bulk RNA测序、Seahorse细胞外通量分析、流式细胞术和多尺度免疫荧光显微镜。
主要发现
- TLR5刺激诱导的IL-1β+NFKB1+IFN-γ+STAT4lo巨噬细胞呈现双相代谢重编程:早期线粒体ATP产生增加,随后TCA循环破坏、代偿性糖酵解和SDH上调。
- 与靶向糖酵解第一步的HK2抑制不同,SDH抑制在TCA循环内干预TLR5诱导的NF-κB/STAT4信号和氧化应激,恢复TCA酶表达和线粒体功能。
- 在TLR5驱动的局部滑膜炎中,SDH抑制通过减少F4/80⁺IL-1β+iNOS⁺SDH⁺巨噬细胞群体并恢复代谢平衡来减轻关节炎症。
关键数值与推荐
- 滑膜中TLR5、SDH、IL-1β、NFKB1和IFN-γ的富集可作为预测性生物标志物。
临床怎么用
- 对于经历疾病发作的RA患者,靶向SDH可能同时改善线粒体功能障碍和炎症。
- 滑膜中TLR5、SDH、IL-1β、NFKB1和IFN-γ的富集可用于识别可能受益于SDH抑制的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Rheumatoid arthritis (RA) is a chronic autoimmune disease in which distinct macrophage (MΦ) endotypes can guide therapy. TLR5, upregulated during disease flares, drives an IL-1β+NFKB1+IFN-γ+STAT4lo MΦ phenotype in blood and synovium that is refractory to tumour necrosis factor (TNF) and IL-6R blockade. This study aimed to identify an alternative strategy to correct inflammation and metabolic dysfunction in these pathogenic MΦs. METHODS: Peripheral blood-derived MΦs and synovial tissue from patients with RA, together with a localised arthritis model, were used to assess responses to succinate dehydrogenase (SDH) inhibition following TLR5 stimulation. We performed bulk RNA sequencing, Seahorse extracellular flux assays, flow cytometry, and multiscale immunofluorescence microscopy spanning whole RA synovium to individual mitochondria. RESULTS: TLR5, SDH, and p65/NFKB1 colocalised in synovial CD14⁺ MΦs and were upregulated in circulation during disease flares. IL-1β+NFKB1+IFN-γ+STAT4lo MΦs elicited by TLR5 stimulation exhibited biphasic metabolic reprogramming, with an early increase in mitochondrial adenosine triphosphate (ATP) production followed by tricarboxylic acid (TCA) cycle disruption, compensatory glycolysis, and SDH upregulation. In contrast to HK2 inhibition, which targets the first step of glycolysis, SDH inhibition within the TCA cycle intercepted TLR5-induced NF-κB/STAT4 signalling and oxidative stress, restoring TCA enzyme expression and mitochondrial function. In localised TLR5-driven synovitis, SDH inhibition attenuated joint inflammation by reducing the population of F4/80⁺IL-1β+iNOS⁺SDH⁺ MΦs and restoring metabolic balance. CONCLUSIONS: SDH functions as a metabolic-immune checkpoint in pathogenic IL-1β+NFKB1+IFN-γ+STAT4lo MΦs in RA. Targeting SDH may concurrently resolve mitochondrial dysfunction and inflammation in patients experiencing disease flares, with synovial enrichment of TLR5, SDH, IL-1β, NFKB1, and IFN-γ serving as predictive biomarkers.
引用
- Zack SR, Satoeya N, Sosa Hernández VA, et al. SDH inhibition quenches rheumatoid arthritis flare-associated IL-1β+IFN-γ+ macrophages via NF-κB/STAT4. Ann Rheum Dis. 2026. PMID: 42697828. doi:10.1016/j.ard.2026.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。